Joseph John Sasadeusz

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
  2. ncbi request reprint Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones
    J Sasadeusz
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    Intern Med J 31:418-21. 2001
  3. ncbi request reprint Why do we not yet have combination chemotherapy for chronic hepatitis B?
    Joseph J Sasadeusz
    Victorian Infectious Diseases Service, and Centre for Clinical Research Excellence in Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria
    Med J Aust 186:204-6. 2007
  4. pmc The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients
    Joe Sasadeusz
    The Alfred Hospital, Melbourne, Victoria, Australia
    AIDS 22:947-55. 2008
  5. doi request reprint Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital
    Joseph John Sasadeusz
    Centre of Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Aust N Z J Obstet Gynaecol 48:266-72. 2008
  6. doi request reprint Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy
    Joseph John Sasadeusz
    Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Melbourne, Vic, Australia
    Addiction 106:977-84. 2011

Collaborators

Detail Information

Publications6

  1. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
    ..Hepatic Flare (HF) after initiation of highly active antiretroviral therapy (HAART) in HIV-HBV coinfected individuals is well recognized but prospective data on predictors and subsequent outcome are limited...
  2. ncbi request reprint Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones
    J Sasadeusz
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    Intern Med J 31:418-21. 2001
    ..The role of chronic low-grade liver function abnormalities remains uncertain and requires further investigation...
  3. ncbi request reprint Why do we not yet have combination chemotherapy for chronic hepatitis B?
    Joseph J Sasadeusz
    Victorian Infectious Diseases Service, and Centre for Clinical Research Excellence in Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria
    Med J Aust 186:204-6. 2007
    ....
  4. pmc The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients
    Joe Sasadeusz
    The Alfred Hospital, Melbourne, Victoria, Australia
    AIDS 22:947-55. 2008
    ....
  5. doi request reprint Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital
    Joseph John Sasadeusz
    Centre of Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Aust N Z J Obstet Gynaecol 48:266-72. 2008
    ..To determine the herpes simplex virus 2 (HSV-2) seroprevalence rate in a Melbourne antenatal cohort...
  6. doi request reprint Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy
    Joseph John Sasadeusz
    Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Melbourne, Vic, Australia
    Addiction 106:977-84. 2011
    ..To evaluate the efficacy, safety and adherence to hepatitis C (HCV) therapy in patients attending tertiary hepatitis clinics who are receiving opioid replacement therapy...